These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Third-time aortic valve replacement: patient characteristics and operative outcome.
    Author: Shaikhrezai K, Tasca G, Amrani M, Dreyfus G, Asimakopoulos G.
    Journal: Ann Thorac Surg; 2010 Feb; 89(2):479-83. PubMed ID: 20103324.
    Abstract:
    BACKGROUND: Reoperative cardiac surgery is being performed with increasing frequency. Third-time aortic valve surgery remains a rare procedure. We retrospectively analyzed the outcome of third-time aortic valve replacement (AVR) at our institution. METHODS: Between 1990 and 2005, 49 patients underwent third-time AVR. Data analyzed included preoperative patient characteristics, type of preexisting aortic valve prosthesis, prosthetic valve pathology necessitating third-time AVR, postoperative morbidity and mortality, and echocardiographic data. RESULTS: The mean age was 47.4 +/- 17 years. The mean interval between the first and second operation was 8.7 +/- 5.7 years, and between the second and third operation it was 10.2 +/- 5.6 years. Prosthetic valves at the time of second AVR included 32 homografts (65.4%), 11 mechanical prostheses (22.4%), and 6 xenografts (12.2%). At third-time AVR, 29 patients (59.2%) received a homograft or autograft, 12 (24.5%) received a mechanical valve, and 8 (16.3%) received a xenograft. In-hospital mortality was 4.1%. The mean follow-up was 80 +/- 69 months. Freedom from reoperation was 84% +/- 6% at 5 years and 65% +/- 11% at 10 years. Long-term survival was 79% +/- 6% at 5 years and 73% +/- 7% at 10 years. Multivariate analysis showed that age, female sex, and postoperative high left ventricular mass were factors associated with decreased long-term survival. Mean left ventricular mass decreased from 320 +/- 133 g to 263 +/- 102 g at 1 year postoperatively (p = 0.01). CONCLUSIONS: Third-time AVR can be performed with low operative mortality, low cumulative operative mortality, and satisfactory long-term survival and freedom from reoperation. The procedure results in significant regression of left ventricular mass.
    [Abstract] [Full Text] [Related] [New Search]